Angiopoietin-like-2: A multifaceted protein with physiological and pathophysiological properties

Studies in Second Language Acquisition

Volumn 16, Issue , 2014, Pages 1-17

  Thorin Trescases, Nathalie ^a   Thorin, Eric ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b Department of Surgery ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOTENSIN 1 RECEPTOR; ANGPTL2 PROTEIN, HUMAN;

ANGIOGENESIS; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PROMOTER REGION; SIGNAL TRANSDUCTION;

ANGIOPOIETINS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; MOLECULAR TARGETED THERAPY; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84912040938     PISSN: 02722631     EISSN: 14701545     Source Type: Journal    
DOI: 10.1017/erm.2014.19     Document Type: Review

References (79)

1. Kim, I. et al. (1999) Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. Journal of Biological Chemistry 274, 26523-8
2. Quagliarini, F. et al. (2012) Atypical angiopoietin-like protein that regulates ANGPTL3. Proceedings of the National Academy of Sciences of the United States of America 109, 19751-6
3. Tabata, M. et al. (2009) Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metabolism 10, 178-88
4. Kadomatsu, T., Tabata, M. and Oike, Y. (2011) Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases. FEBS Journal 278, 559-64
5. Li, Q. et al. (2013) Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes. Diabetes Research & Clinical Practice 100, 385-90
6. Usui, T. et al. (2013) Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study. Circulation Journal 77, 2311-7
7. Odagiri, H. et al. (2014) The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin alpha5beta1, p38 MAPK, and matrix metalloproteinases. Science Signaling 7, ra7
8. Broxmeyer, H.E. et al. (2011) Angiopoietin-like-2 and -3 act through their coiled-coil domains to enhance survival and replating capacity of human cord blood hematopoietic progenitors. Blood Cells Molecules and Diseases 48, 25-9
9. Kubota, Y. et al. (2005) Cooperative interaction of Angiopoietin-like proteins 1 and 2 in zebrafish vascular development. Proceedings of the National Academy of Sciences of the United States of America 102, 13502-7
10. Zheng, J. et al. (2012) Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature 485, 656-60
11. Horio, E. et al. (2014) Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arteriosclerosis Thrombosis & Vascular Biology 34, 790-800
12. Oike, Y. and Tabata, M. (2009) Angiopoietin-like proteins - potential therapeutic targets for metabolic syndrome and cardiovascular disease. Circulation Journal 73, 2192-7
13. Fan, X. et al. (2014) Paired immunoglobin-like receptor B regulates platelet activation. Blood 124, 2421-30
14. Farhat, N. et al. (2013) Angiopoietin-like 2 promotes atherogenesis in mice. Journal of American Heart Association 2, e000201
15. Toyono, T. et al. (2013) Angiopoietin-like protein 2 is a potent hemangiogenic and lymphangiogenic factor in corneal inflammation. Investigative Ophthalmology & Visual Science 54, 4278-85
16. Richardson, M.R. et al. (2014) Angiopoietin-like protein 2 regulates endothelial colony forming cell vasculogenesis. Angiogenesis 17, 675-683
17. Aoi, J. et al. (2011) Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Research 71, 7502-12
18. Aoi, J. et al. (2014) Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress. Molecular Cancer Research 12, 239-249
19. Mederle, K. et al. (2013) The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Critical Care 17, R130
20. Tazume, H. et al. (2012) Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arteriosclerosis Thrombosis & Vascular Biology 32, 1400-9
21. Tian, Z. et al. (2013) Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. Journal of Molecular & Cellular Cardiology 57, 1-12
22. Yu, C. et al. (2013) Angiopoietin like-2 (Angptl2) knock-down limits high-fat diet-induced fat accumulation, hypercholesterolemia and prevents endothelial dysfunction in mice. Circulation 128, A14771
23. Yu, C. et al. (2014) Lack of angiopoietin-like-2 expression limits the metabolic stress induced by a high-fat diet and maintains endothelial function in mice. Journal of American Heart Association 3, e001024
24. Kadomatsu, T. et al. (2014) Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends in Endocrinology & Metabolism 25, 245-54
25. Oike, Y., Yasunaga, K. and Suda, T. (2004) Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. International Journal of Hematology 80, 21-8
26. Hato, T., Tabata, M. and Oike, Y. (2008) The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends in Cardiovascular Medicine 18, 6-14
27. Akhter, S. et al. (2013) Dynamic roles of angiopoietin-like proteins 1, 2, 3, 4, 6 and 7 in the survival and enhancement of ex vivo expansion of bone-marrow hematopoietic stem cells. Protein & Cell 4, 220-30
28. Zhang, C.C. et al. (2006) Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nature Medicine 12, 240-5
29. Deng, M. et al. (2014) A motif in LILRB2 critical for Angptl2 binding and activation. Blood 124, 924-35
30. Kubota, Y. (2014) Unveiling Angptl2, a rising HSC expander. Blood 124, 833-4
31. Guo, D.F. et al. (2006) Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension 48, 453-9
32. Guo, D.F. et al. (2003) Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochemical and Biophysical Research Communications 310, 1254-65
33. Guo, D.F. et al. (2001) The angiotensin II type 1 receptor and receptor-associated proteins. Cell Research 11, 165-80
34. Endo, M. et al. (2012) Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Research 72, 1784-94
35. Sasaki, H. et al. (2012) Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer. Oncology Letters 4, 1325-1328
36. Szarc Vel Szic, K. et al. (2014) Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS ONE 9, e87850
37. Teicher, B.A. (2012) Searching for molecular targets in sarcoma. Biochemical Pharmacology 84, 1-10
38. Endo, M. et al. (2014) Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis. International Journal of Biological Markers 29, e239-45
39. Gao, L. et al. (2014) ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma. Journal of Gastroenterology & Hepatology (epub)
40. Zhou, J. et al. (2014) Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer. International Journal of Molecular Medicine 34, 1286-92
41. Doi, Y. et al. (2013) Angiopoietin-like protein 2 and risk of type2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care 36, 98-100
42. Meng, Q.X. et al. (2013) Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: in vitro and in vivo evidence. Experimental and Therapeutic Medicine 5, 1631-1636
43. Muramoto, A. et al. (2011) Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men. Nutrition & Diabetes 1, e20
44. Okada, T. et al. (2010) Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. American Journal of Pathology 176, 2309-19
45. Ogata, A. et al. (2012) The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis. Biochemical and Biophysical Research Communications 418, 494-9
46. Nakamura, T. et al. (2014) Angiopoietin-like protein 2 induced by mechanical stress accelerates degeneration and hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis. PLoS ONE 9, e85542
47. Santulli, G. (2014) Angiopoietin-like proteins: a comprehensive look. Frontiers in Endocrinology (Lausanne) 5, 4
48. Morisada, T. et al. (2006) Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium 13, 71-9
49. Swain, L. et al. (2014) Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions. Journal of Leukocyte Biology 96, 365-75
50. Mitko, K. et al. (2008) Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle. Reproduction 135, 225-40
51. Haddad, R. et al. (2008) Angiogenesis gene expression in mouse uterus during the common pathway of parturition. American Journal of Obstetrics & Gynecology 198, 539, e1-8
52. Niki, D., Katsu, K. and Yokouchi, Y. (2009) Ontogeny of angiopoietin-like protein 1, 2, 3, 4, 5, and 7 genes during chick embryonic development. Development Growth and Differentiation 51, 821-32
53. Buga, A.M. et al. (2014) Transcriptomics of post-stroke angiogenesis in the aged brain. Frontiers in Aging Neuroscience 6, 44
54. Lee, S. et al. (2012) Identification of genes underlying different methylation profiles in refractory anemia with excess blast and refractory cytopenia with multilineage dysplasia in myelodysplastic syndrome. Korean Journal of Hematology 47, 186-93
55. Castrop, H. (2013) Angiotensin receptor-associated proteins: local modulators of the renin-angiotensin system. Pflugers Archiv 465, 111-9
56. Higuchi, S. et al. (2007) Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clinical Science (London) 112, 417-28
57. Doblinger, E. et al. (2012) Angiotensin AT1 receptor-associated protein Arap1 in the kidney vasculature is suppressed by angiotensin II. American Journal of Physiology - Renal Physiology 302, F1313-24
58. Kitazawa, M. et al. (2011) Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes. Endocrinology 152, 2558-67
59. Kadomatsu, T. et al. (2013) A molecular clock regulates angiopoietin-like protein 2 expression. PLoS ONE 8, e57921
60. Kikuchi, R. et al. (2008) Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Cancer Research 68, 5067-75
61. Kenney, S. et al. (2011) ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma. Journal of Pediatric Hematology-Oncology 33, 360-8
62. Stockwin, L.H. et al. (2009) Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC Cancer 9, 22
63. Tateya, S., Kim, F. and Tamori, Y. (2013) Recent advances in obesity-induced inflammation and insulin resistance. Frontiers in Endocrinology (Lausanne) 4, 93
64. Sun, H. et al. (2007) Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy. Nephron Experimental Nephrology 105, e117-23
65. Farhat, N. et al. (2008) Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Canadian Journal of Physiology and Pharmacology 86, 761-9
66. Horio, E. et al. (2010) Angiopoietin-like protein 2 (angptl2) promotes coronary endothelial dysfunction and atherosclerosis. Circulation 122, Abstract 11343
67. Horio, E. et al. (2013) Vascular tissue-derived Angptl2 accelerates atherosclerosis through increased vascular inflammation. Circulation 128, Abstract 13942
68. Miida, T. and Hirayama, S. (2010) Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Current Opinion in Lipidology 21, 70-5
69. Shimizu, I. and Walsh, K. (2013) Vascular remodeling mediated by Angptl2 produced from perivascular adipose tissue. Journal of Molecular & Cellular Cardiology 59, 176-8
70. Dei Cas, A. and Gnudi, L. (2012) VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment? Metabolism 61, 1666-73
71. Kanda, A. et al. (2012) Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye. Laboratory Investigation 92, 1553-63
72. Ambati, B. (2013) A new target for simultaneous inhibition of hem- and lymphangiogenesis. Investigative Ophthalmology & Visual Science 54, 4286
73. Zheng, J.Y. et al. (2011) Tumor necrosis factor-alpha increases angiopoietin-like protein 2 gene expression by activating Foxo1 in 3T3-L1 adipocytes. Molecular and Cellular Endocrinology 339, 120-9
74. Lee, H.J. et al. (2013) Angiopoietin-like protein 2, a chronic inflammatory mediator, is a new target induced by TGF-beta1 through a Smad3-dependent mechanism. Biochemical and Biophysical Research Communications 430, 981-6
75. Jung, J.H. et al. (2010) Mel-18, a mammalian Polycomb gene, regulates angiogenic gene expression of endothelial cells. Biochemical and Biophysical Research Communications 400, 523-30
76. Fu, Z. et al. (2013) Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochemical and Biophysical Research Communications 430, 1126-31
77. Li, C. (2006) Genetics and regulation of angiopoietin-like proteins 3 and 4. Current Opinion in Lipidology 17, 152-6
78. Mattijssen, F. and Kersten, S. (2012) Regulation of triglyceride metabolism by Angiopoietin-like proteins. Biochimica et Biophysica Acta 1821, 782-9
79. Savoia, C. et al. (2011) Angiotensin II and the vascular phenotype in hypertension. Expert Reviews in Molecular Medicine 13, e11